Vascular responses to leukocyte products in atherosclerotic primates

Circulation Research
J A LopezD D Heistad

Abstract

Little is known about the possible role of leukocytes in the pathogenesis of vasospasm. We hypothesized that vasoactive products released by leukocytes might produce constriction of atherosclerotic arteries. To test this hypothesis, we infused fmet-leu-phe (fMLP), a peptide that activates leukocytes to release their vasoactive products, into the perfused hind limb of normal and atherosclerotic cynomolgus monkeys. Infusion of fMLP did not change resistance of large arteries in normal monkeys. In contrast, fMLP produced pronounced constriction of large arteries in atherosclerotic monkeys. To determine whether leukotrienes, platelet-activating factor, or prostaglandin E2 (PGE2), which are released by leukocytes, may contribute to leukocyte-induced vasoconstriction in atherosclerotic monkeys, we injected leukotriene D4, platelet-activating factor, and PGE2 intra-arterially into the perfused hind limb. Leukotriene D4 and platelet-activating factor had minimal effects on large arteries in both normal and atherosclerotic monkeys. PGE2 produced marked constriction of large arteries in atherosclerotic, but not normal, monkeys. Thus, pronounced constriction in atherosclerotic, but not normal, arteries during infusion of fMLP suggests tha...Continue Reading

References

Mar 1, 1986·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·L JonassonG K Hansson
Jan 1, 1985·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·M B Zucker, V T Nachmias
Oct 1, 1987·British Journal of Pharmacology·E CoëffierB B Vargaftig
Jun 1, 1988·The Journal of Clinical Investigation·H YamamotoP D Henry
Sep 1, 1987·Prostaglandins, Leukotrienes, and Medicine·P HenrikssonU Diczfalusy
Oct 1, 1985·Circulation·P M Vanhoutte, D S Houston
Jul 1, 1985·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·M L ArmstrongD J Piegors
Nov 30, 1984·Biochemical and Biophysical Research Communications·B DewaldM Baggiolini
Jan 1, 1984·The American Journal of Physiology·R Takemura, Z Werb
Jan 7, 1983·Biochimica Et Biophysica Acta·C E WalshM Waite
Sep 1, 1984·The Journal of Allergy and Clinical Immunology·N A PawlowskiW A Scott
Jul 1, 1984·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·A FaggiottoL Harker
Jan 1, 1984·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·P H RollandA Serradimigni
Jul 1, 1980·The American Journal of Cardiology·R N MacAlpin
Jan 1, 1983·The Journal of Clinical Investigation·M L ArmstrongF M Abboud
Dec 1, 1981·Prostaglandins and Medicine·D AharonyA M Lefer
Aug 1, 1980·The Journal of Clinical Investigation·P D Henry, M Yokoyama

❮ Previous
Next ❯

Citations

Jul 5, 1996·International Journal of Cardiology·Y AbeY Maruyama
Aug 1, 1992·Journal of the American College of Cardiology·J K WilliamsT B Clarkson
Mar 1, 1995·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·A Chinellato, E Ragazzi
May 29, 2004·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Haim TapieroKenneth D Tew
Jan 1, 1997·Progress in Cardiovascular Diseases·G R De Meyer, A G Herman
Feb 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·C R WhiteB A Freeman
Nov 1, 1996·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·R HärtlG J del Zoppo
Feb 11, 1995·Lancet·G K GoodeA M Heagerty
Jul 17, 2008·Archives of Physiology and Biochemistry·Miguel A IñiguezManuel Fresno
Jul 11, 1992·Progress in Cardiovascular Diseases·A P SelwynP Ganz
May 1, 1992·Progress in Cardiovascular Diseases·J FareedR Pifarre
Dec 1, 1991·Baillière's Clinical Obstetrics and Gynaecology·M R AdamsM J Jayo
Dec 14, 2006·Prostaglandins & Other Lipid Mediators·Kristina M FetalveroJohn Hwa
Mar 1, 1992·Atherosclerosis·R CirilloM Prosdocimi
Jul 1, 1993·European Journal of Clinical Investigation·S MoncadaA Higgs
Jun 1, 1991·Stroke; a Journal of Cerebral Circulation·F M FaraciD D Heistad
Mar 1, 1991·Hypertension·A Mügge, J A Lopez
Apr 18, 1994·Annals of the New York Academy of Sciences·S KaulD D Heistad
Jan 1, 1991·Annals of Medicine·A MüggeP R Lichtlen
May 1, 1996·Pflügers Archiv : European journal of physiology·M SetoY Sasaki
Jul 25, 2017·Experimental Physiology·Shinichi AsanoPaul D Chantler
Mar 1, 1994·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·A S LübbeP D Harris

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.